These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11124429)

  • 1. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis.
    Cummings JL
    Neurobiol Aging; 2000; 21(6):845-61. PubMed ID: 11124429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.
    Shepherd A; Tyebji S; Hannan AJ; Burrows EL
    J Mol Neurosci; 2016 Nov; 60(3):371-382. PubMed ID: 27637601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological correlates of apathy in mild cognitive impairment and Alzheimer's disease: the role of executive functioning.
    Drijgers RL; Verhey FR; Leentjens AF; Köhler S; Aalten P
    Int Psychogeriatr; 2011 Oct; 23(8):1327-33. PubMed ID: 21729413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription.
    Benoit M; Andrieu S; Lechowski L; Gillette-Guyonnet S; Robert PH; Vellas B;
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):409-14. PubMed ID: 17918770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
    Koppel J; Sunday S; Goldberg TE; Davies P; Christen E; Greenwald BS;
    Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease.
    Levy ML; Cummings JL; Kahn-Rose R
    Gerontology; 1999; 45 Suppl 1():15-22. PubMed ID: 9876214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of cognitive function, behavioral and psychological symptoms in patients with Alzheimer's disease versus behavioral variant frontotemporal dementia].
    Zhang LL; Wang Y; Cheng Y; Zhang N
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):903-908. PubMed ID: 29202529
    [No Abstract]   [Full Text] [Related]  

  • 8. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.
    Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G
    Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closing-in is related to apathy in Alzheimer's disease patients.
    Grossi D; de Lucia N; Trojano L
    J Alzheimers Dis; 2015; 43(3):849-55. PubMed ID: 25125462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease.
    Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 38(2):319-29. PubMed ID: 23963290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apathy in Alzheimer's disease: A neurocircuitry based perspective.
    Mehak SF; Shivakumar AB; Saraf V; Johansson M; Gangadharan G
    Ageing Res Rev; 2023 Jun; 87():101891. PubMed ID: 36871779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric Symptoms Predict Functional Status in Alzheimer's Disease.
    You SC; Walsh CM; Chiodo LA; Ketelle R; Miller BL; Kramer JH
    J Alzheimers Dis; 2015; 48(3):863-9. PubMed ID: 26402074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.
    Dodich A; Cerami C; Cappa SF; Marcone A; Golzi V; Zamboni M; Giusti MC; Iannaccone S
    J Alzheimers Dis; 2018; 61(2):761-772. PubMed ID: 29254091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
    Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease.
    Cummings JL; Back C
    Am J Geriatr Psychiatry; 1998; 6(2 Suppl 1):S64-78. PubMed ID: 9581223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology.
    Kosel F; Pelley JMS; Franklin TB
    Neurosci Biobehav Rev; 2020 May; 112():634-647. PubMed ID: 32070692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.